Cargando…
The protein tyrosine kinase inhibitor, Genistein, delays intervertebral disc degeneration in rats by inhibiting the p38 pathway-mediated inflammatory response
The treatment for intervertebral disc degeneration (IDD) has drawn great attention and recent studies have revealed that the p38 MAPK pathway is a potential therapeutic target for delaying the degeneration of intervertebral discs. In this study, we analyzed a nature-derived protein tyrosine kinase i...
Autores principales: | Ge, Jun, Zhou, Quan, Cheng, Xiaoqiang, Qian, Jiale, Yan, Qi, Wu, Cenhao, Chen, Yufeng, Yang, Huilin, Zou, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041767/ https://www.ncbi.nlm.nih.gov/pubmed/32023553 http://dx.doi.org/10.18632/aging.102743 |
Ejemplares similares
-
Calcitonin inhibits intervertebral disc degeneration by regulating protein kinase C
por: Ge, Jun, et al.
Publicado: (2020) -
Melatonin Protects Intervertebral Disc from Degeneration by Improving Cell Survival and Function via Activation of the ERK1/2 Signaling Pathway
por: Ge, Jun, et al.
Publicado: (2019) -
Tea Polyphenol Attenuates Oxidative Stress-Induced Degeneration of Intervertebral Discs by Regulating the Keap1/Nrf2/ARE Pathway
por: Song, Dawei, et al.
Publicado: (2021) -
Syndecan-4 is a Novel Therapeutic Target for Intervertebral Disc Degeneration via Suppressing JNK/p53 Pathway
por: Ge, Jun, et al.
Publicado: (2020) -
Nimbolide targeting SIRT1 mitigates intervertebral disc degeneration by reprogramming cholesterol metabolism and inhibiting inflammatory signaling
por: Teng, Yun, et al.
Publicado: (2023)